Abbott Laboratories (ABT) lost ~5% in the premarket on Thursday after the MedTech giant reported lower-than-expected revenue for Q4 2025 following underperformance in its Nutrition segment. The ...

Abbott’s stock has fallen by over 7% despite reporting strong fiscal year 2025 (FY25) revenues of $44.32bn, representing a ...

Abbott Laboratories' $21 billion acquisition of Exact Sciences is fueling optimism that a long deal drought in health care is finally breaking — a potentially good sign for Illinois' health and ...

The health care sector has declined by 0.18% in 2025. This is better than the S&P 500’s drop of 6.06%. The Health Care Select Sector SPDR Fund (XLV) is graphed below. Looking within the sector is ...

ABBOTT PARK, Ill., April 29, 2025 /PRNewswire/ -- Abbott (NYSE: ABT), the global leader in continuous glucose monitoring (CGM) biowearable technology 1, today announced that it has entered a ...

Abbott Laboratories announced full-year guidance that was down from its earlier expectations, which the North Chicago-based company said were formed before tariffs were announced. Abbott’s shares fell ...

Global healthcare company Abbott is collaborating with MATTER, the Chicago-based healthcare incubator, to advance innovation in healthcare. Abbott joins seven other healthcare organizations as a ...